Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.

How has the human embryonic stem cells market size evolved in recent years?

The market size for human embryonic stem cells has witnessed impressive expansion in the past few years. The projection states it will increase from $1.24 billion in 2024 to approximately $1.37 billion in 2025, with a compound annual growth rate (CAGR) of 10.5%. The notable growth during the historical period is the result of various contributing factors like capital inflow and investments, regulatory sanctity, rise in public awareness, the advent of regenerative medicine, and wider clinical applications.

What are the predictions for the human embryonic stem cells market size in the coming years?

A significant expansion is anticipated in the human embryonic stem cells market in the following years, with it set to reach a valuation of $2.02 billion in 2029, exhibiting a compound annual growth rate (CAGR) of 10.1%. The upward trend during this forecast period can be accredited to the surge in cell therapy production facilities, greater demand for regenerative therapies, increasing incidence of cardiac and malignant diseases, breakthroughs in stem cell biology research, and an enhanced understanding of stem cell therapeutic potential. Key trends identified for the predicted period are advancements in regenerative medicine, an emphasised focus on individualised medicine, a spike in uses in drug discovery and toxicology testing, technological breakthroughs, and growth in biobanking.

Get your human embryonic stem cells market report here!

https://www.thebusinessresearchcompany.com/report/human-embryonic-stem-cells-global-market-report

What key factors are fueling the growth of the human embryonic stem cells market?

The expansion of the human embryonic stem cells market is set to be encouraged by government investments in the progress of regenerative medicine. The medical industry is enhancing its focus on regenerative medicine, which is concerned with the healing or replacement of damaged organs or tissues to restore regular bodily functions. Factors such as the increasing occurrence of chronic diseases, advances in stem cell research, and the potential of transformative treatments to elevate patient results have contributed to increased government financial support for regenerative medicine development. Human embryonic stem cells play a crucial role in regenerative medicine by providing potential therapies for healing or substituting damaged body organs and tissues. For example, in May 2022, the stem cell network, under the administration of the Government of Canada, was granted a funding of $45 million for a period of three years starting from 2022-23. This allocation, part of the 2021 Budget, is intended to reinforce research in stem cells and regenerative medicine. Hence, the government’s financial backing for the advancement of regenerative medicine is a significant driver for the growth of the human embryonic stem cells market.

How is the global human embryonic stem cells market divided into key segments?

The human embryonic stem cells market covered in this report is segmented –

1) By Type: Totipotent Stem Cells, Pluripotent Stem Cells, Unipotent Stem Cells

2) By Product: Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering, Toxicology Testing

3) By Application: Research, Clinical Trials, Other Applications

Subsegments:

1) By Totipotent Stem Cells: Embryonic Totipotent Stem Cells, Induced Totipotent Stem Cells

2) By Pluripotent Stem Cells: Human Embryonic Stem Cells (hESCs), Induced Pluripotent Stem Cells (iPSCs), Embryonic Stem Cell Lines, Conditioned Pluripotent Stem Cells

3) By Unipotent Stem Cells: Somatic Stem Cells, Adult Stem Cells, Tissue-Specific Stem Cells

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16086&type=smp

Who are the key firms paving the way for growth in the human embryonic stem cells market?

Major companies operating in the human embryonic stem cells market are Thermo Fisher Scientific Inc., Takeda Pharmaceutical Company Limited, Gilead Sciences Inc., Merck KgaA, Astellas Pharma Inc., Lonza Group, PerkinElmer Inc., R&D Systems, LifeCell, Takara Bio Inc., ViaCyte Inc., PromoCell GmbH, CellGenix GmbH, PeproTech Inc., Lineage Cell Therapeutics Inc., BioTime, Asterias Biotherapeutics Inc., ESI BIO, STEMCELL Technologies Inc., TATAA Biocenter, Celgene Corporation

What key trends are currently impacting the human embryonic stem cells market’s development?

Leading companies in the human embryonic stem cell sector are striving to branch out into various therapeutic uses, like using pluripotent stem cells for the treatment of Parkinson’s disease, to gain a competitive market advantage. These pluripotent stem cells are utilized to create dopaminergic neurons, with the goal of replacing the dopamine-producing neurons that have been lost, and reinstating motor function. For example, in October 2023, Bayer AG, a pharmaceutical and biotech company from Germany, invested $250 million and inaugurated its very first Cell Therapy Manufacturing Facility in California. This allowed them to globally produce cell and gene therapies. Initially, the new facility prioritized the production of BlueRock Therapeutics’ bemdaneprocel, which is derived from pluripotent stem cells, for Parkinson’s disease. The facility is equipped with completely electric manufacturing to meet the manufacturing demands of regenerative medicines in the industry.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16086

What regions are contributing significantly to the growth of the human embryonic stem cells market?

North America was the largest region in the human embryonic stem cells market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the human embryonic stem cells market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Automotive Human-Machine Interfaces Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/automotive-human-machine-interfaces-global-market-report

Human Capital Management Global Market Opportunities And Strategies To 2032

https://www.thebusinessresearchcompany.com/report/human-capital-management-market

Human Liver Model Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/human-liver-model-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: